Trade

with

Spectrum Pharmaceuticals Inc
(NASDAQ: SPPI)
AdChoices
7.62
+0.13
+1.74%
After Hours :
7.62
0.00
0.00%

Open

7.54

Previous Close

7.49

Volume (Avg)

591.89k (853.26k)

Day's Range

7.44-7.65

52Wk Range

6.36-10.32

Market Cap.

500.88M

Dividend Rate ( Yield )

-

Beta

1.97

Shares Outstanding

65.73M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 155.85M

    • Net Income

    • -62.13M

    • Market Cap.

    • 500.88M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -45.74

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.97

    • Forward P/E

    • -117.65

    • Price/Sales

    • 2.82

    • Price/Book Value

    • 1.89

    • Price/Cash flow

    • -15.87

      • EBITDA

      • -16.69M

      • Return on Capital %

      • -16.78

      • Return on Equity %

      • -28.71

      • Return on Assets %

      • -16.78

      • Book Value/Share

      • 4.04

      • Shares Outstanding

      • 65.73M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 15.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -0.07

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 41.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 40.25

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 84.23

            • 82.75

            • Pre-Tax Margin

            • -28.43

            • 39.38

            • Net Profit Margin

            • -45.74

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 80.30

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -17.00

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -19.10

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.35

              • 0.76

              • Current Ratio

              • 2.84

              • 2.92

              • Quick Ratio

              • 2.64

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.79

              • 2.21

              • Book Value/Share

              • 4.04

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.06

                • 196.08

                • P/E Ratio 5-Year High

                • -14.15

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.97

                • 124.82

                • Price/Sales Ratio

                • 2.77

                • 9.12

                • Price/Book Value

                • 1.85

                • 8.26

                • Price/Cash Flow Ratio

                • -15.87

                • 47.39

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -28.71

                        (-4.90)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -16.78

                        (-1.70)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -22.71

                        (-4.70)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 2.06

                      • 1.48

                      • Asset Turnover

                      • 0.37

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -38.78M
                      Operating Margin
                      -24.89
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -15.87
                      Ownership

                      Institutional Ownership

                      67.96%

                      Top 10 Institutions

                      39.86%

                      Mutual Fund Ownership

                      37.90%

                      Float

                      84.95%

                      5% / Insider Ownership

                      4.62%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        3,903,900

                      • 0.00

                      • 5.94

                      • SPDR® S&P Biotech ETF

                      •  

                        2,143,594

                      • 3.60

                      • 3.00

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,211,425

                      • 25.81

                      • 1.84

                      • iShares Core S&P Small-Cap (AU)

                      •  

                        1,157,774

                      • 0.25

                      • 1.62

                      • iShares Russell 2000 (AU)

                      •  

                        1,017,499

                      • -1.02

                      • 1.42

                      • Vanguard Small Cap Index

                      •  

                        973,062

                      • 0.16

                      • 1.48

                      • iShares Nasdaq Biotechnology

                      •  

                        872,638

                      • -0.69

                      • 1.22

                      • iShares US Pharmaceuticals

                      •  

                        755,405

                      • 0.93

                      • 1.06

                      • Vanguard Small Cap Growth Index Fund

                      •  

                        655,789

                      • -1.76

                      • 1.00

                      • F&C Global Smaller Companies

                      •  

                        609,603

                      • 0.00

                      • 0.93

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Millennium Management LLC

                      •  

                        4,694,155

                      • -0.19%

                      • 7.14

                      • BlackRock Fund Advisors

                      •  

                        4,613,164

                      • +14.85%

                      • 7.02

                      • Fidelity Management and Research Company

                      •  

                        4,242,147

                      • -7.52%

                      • 6.45

                      • Vanguard Group, Inc.

                      •  

                        3,745,639

                      • +0.89%

                      • 5.70

                      • State Street Corp

                      •  

                        2,782,779

                      • -17.31%

                      • 4.23

                      • BMO Asset Management Inc.

                      •  

                        1,499,834

                      • +567.95%

                      • 2.28

                      • Dimensional Fund Advisors, Inc.

                      •  

                        1,248,240

                      • -0.48%

                      • 1.90

                      • Goldman, Sachs & Co.

                      •  

                        1,223,321

                      • -10.61%

                      • 1.86

                      • Rothschild Asset Management, Inc.

                      •  

                        1,112,790

                      • +13.95%

                      • 1.69

                      • Royal Bank Of Canada

                      •  

                        1,042,118

                      • +2.13%

                      • 1.59

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      Spectrum Pharmaceuticals Inc was incorporated in Colorado in December 1987 as Americus Funding Corporation and reincorporated in Delaware in June 1997. The Company changed its corporate name in August 1996 to NeoTherapeutics, Inc., a...morend to Spectrum Pharmaceuticals, Inc in December 2002. The Company and its wholly-owned subsidiaries is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology. The Company market four oncology drugs: FUSILEV injection, ZEVALIN injection, FOLOTYN injection, and MARQIBO injection. Its product portfolio consisting of both commercial stage and development stage products that address various cancer types. FUSILEV, a novel folate analog formulation and the pharmacologically active isomer (the levo...more-isomer) of the racemic compound, calcium leucovorin. FOLOTYN, a folate analogue metabolic inhibitor, was discovered by Memorial Sloan-Kettering Cancer Center, SRI International and Southern Research Institute and developed by Allos Therapeutics, Inc. ZEVALIN injection for intravenous use is a prescription medication that is part of a three step treatment regimen consisting of: two treatments of rituximab and one treatment of Yttrium-90 (Y-90) ZEVALIN. MARQIBO is a novel, sphingomyelin/cholesterol liposome-encapsulated formulation of the FDA-approved anticancer drug vincristine. The Company markets and sells its drugs through a direct sales force in the U.S., and through distributors in Europe and Japan. The Company competes with Astra Zeneca PLC, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Co., Novartis AG, Genentech, Inc. (Roche), Bristol-Myers Squibb Company, GlaxoSmithKline, Biogen-IDEC Pharmaceuticals, Inc., OSI Pharmaceuticals, Inc. (Astellas Pharma), Cephalon, Inc. (Teva Pharmaceuticals), Sanofi-Aventis, Inc., Pfizer, Inc., Genta Incorporated, Merck, Celgene Corporation, BiPar Sciences, Inc., Genzyme Corporation, Shire Pharmaceuticals, Abbott Laboratories, Poniard Pharmaceuticals, Inc., and Johnson & Johnson. The development, production and marketing of its proprietary and generic drug and biologic products are subject to regulation for safety, efficacy and quality by numerous governmental authorities in the U.S. and other countries.lessless

                      Key People

                      Dr. Rajesh C. Shrotriya,M.D.

                      CEO/Chairman of the Board/Director

                      Kurt A. Gustafson

                      CFO/Chief Accounting Officer/Executive VP

                      Dr. Anthony E. Maida, III

                      Director

                      Dr. Stuart M. Krassner,Sc.D.,Psy.D.

                      Director

                      Dr. Luigi Lenaz,M.D.

                      Director

                      • Spectrum Pharmaceuticals Inc

                      • 11500 South Eastern Avenue

                      • Henderson, NV 89052

                      • USA.Map

                      • Phone: +1 702 835-6300

                      • Fax: +1 702 260-7405

                      • sppirx.com

                      Incorporated

                      1987

                      Employees

                      226

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: